Skip to main content
SpringerLink
Log in

Ciclosporin oder Infliximab bei schwerer steroidrefraktärer Colitis ulcerosa

GETAID-Studie (Group d’Etudes Thérapeutiques des Affections Inflammatoires Digestives)

Ciclosporin or infliximab for severe steroid refractory ulcerative colitis

GETAID study (Group d’Etudes Thérapeutiques des Affections Inflammatoires Digestives)

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Chang KH, Burke JP, Coffey JC (2013) Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis. Int J Colorectal Dis 28:287–293

    Article  PubMed  Google Scholar 

  2. Dignass A, Lindsay JO, Sturm A et al (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: current management. J Crohns Colitis 6:991–1030

    Google Scholar 

  3. Dignass A, Preiß JC, Aust DE et al (2011) Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 – Ergebnisse einer evidenzbasierten Konsensuskonferenz. Z Gastroenterol 49:1276–1341

    Google Scholar 

  4. Levesque BG, Sandborn WJ (2012) Infliximab versus ciclosporin in severe ulcerative colitis. Lancet 380:1887–1888

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. M. Zeitz: keine Angabe. S. Nitschmann gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland

    M. Zeitz †

  2. Werl-Westönnen, Deutschland

    S. Nitschmann

Authors
  1. M. Zeitz †
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zeitz †, M., Nitschmann, S. Ciclosporin oder Infliximab bei schwerer steroidrefraktärer Colitis ulcerosa. Internist 55, 223–224 (2014). https://doi.org/10.1007/s00108-013-3434-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-013-3434-1

Search

Navigation